Rocío Olmedo-Requena

Dr. Rocío Olmedo-Requena

University of Granada, Granada, Andalusia, Spain
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2018 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
OROn Behalf Of Mcc-Spain Researchers
On Behalf Of Mcc-Spain Researchers
APAdela Castelló Pastor
Adela Castelló Pastor
PAPilar Amiano
Pilar Amiano
NLNerea Fernández de Larrea
Nerea Fernández de Larrea
VMVicente Martín
Vicente Martín
MPMarina Pollán
Marina Pollán

1 April 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
DRDora Romaguera
Dora Romaguera
SFSílvia Fernández-Barrés
Sílvia Fernández-Barrés
EGEsther Gracia-Lavedán
Esther Gracia-Lavedán
EVEva Vendrell
Eva Vendrell
MAMikel Azpiri
Mikel Azpiri
PAPilar Amiano
Pilar Amiano

7 December 2015 in Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PDF file
ALAnne-Mary Lewis-Mikhael
Anne-Mary Lewis-Mikhael
ABAurora Bueno-Cavanillas
Aurora Bueno-Cavanillas
TGTalia Ofir Guiron
Talia Ofir Guiron
RORocío Olmedo-Requena
Rocío Olmedo-Requena
MDMiguel Delgado-Rodríguez
Miguel Delgado-Rodríguez
JJJose J. Jimenez-Moleon
Jose J. Jimenez-Moleon
Epidemiological studies on exposure to pesticides and risk of prostate cancer (PC) provide inconsistent results. We aimed to explore various potential sources of heterogeneity not previously assessed and to derive updated risk estimates from homogenous studies. We searched PubMed, Web of Science and Scopus databases for case–control and cohort studies published from 1985 to April 2014. We assessed the quality of the articles using the Newcastle-Ottawa Scale. Pooled estimates were calculated using random-effects models. Heterogeneity was explored using subset analyses and metaregression. Fifty-two studies were included in the review and 25 in the meta-analysis. No association was found between low exposure to pesticides and PC, but association was significant for high exposure, pooled OR 1.33 (1.02 to 1.63), I2=44.8%, p=0.024. Heterogeneity was explained by a number of variables including method used to assess exposure. Pooled OR was weak and non-significant for studies measuring serum pesticide level, 1.12 (0.74 to 1.50), I2=0.00%, p=0.966. For studies applying self-reporting of exposure, pooled estimate was 1.34 (0.91 to 1.77), I2=0.00%, p=0.493, while a high significant association was detected for grouped exposure assessment, 2.24 (1.36 to 3.11), I2=0.00%, p=0.955. In spite of a weak significant association detected when pooling ORs for high occupational exposure to pesticides, the magnitude of the association was related to the method of exposure assessment used by the original studies. A family history–pesticide exposure interaction was also observed for a number of pesticides.

5 April 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
DRDora Romaguera
Dora Romaguera
EGEsther Gracia‐Lavedan
Esther Gracia‐Lavedan
AMAmaia Molinuevo
Amaia Molinuevo
JBJordi de Batlle
Jordi de Batlle
MMMichelle Mendez
Michelle Mendez
PAPilar Amiano
Pilar Amiano
Prostate, breast and colorectal cancer are the most common tumours in Spain. The aim of the present study was to evaluate the association between adherence to nutrition‐based guidelines for cancer prevention and prostate, breast and colorectal cancer, in the MCC‐Spain case–control study. A total of 1,718 colorectal, 1,343 breast and 864 prostate cancer cases and 3,431 population‐based controls recruited between 2007 and 2012, were included in the present study. The World Cancer Research Fund/American Institute for Cancer Research (WCRC/AICR) score based on six recommendations for cancer prevention (on body fatness, physical activity, foods and drinks that promote weight gain, plant foods, animal foods and alcoholic drinks; score range 0–6) was constructed. We used unconditional logistic regression analysis adjusting for potential confounders. One‐point increment in the WCRF/AICR score was associated with 25% (95% CI 19–30%) lower risk of colorectal, and 15% (95% CI 7–22%) lower risk of breast cancer; no association with prostate cancer was detected, except for cases with a Gleason score ≥7 (poorly differentiated/undifferentiated tumours) (OR 0.87, 95% CI 0.76–0.99). These results add to the wealth of evidence indicating that a great proportion of common cancer cases could be avoided by adopting healthy lifestyle habits.

1 February 2017 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
PDF file
PAPatrocinio Ariza-Vega
Patrocinio Ariza-Vega
Mario LozanoMario Lozano
Mario Lozano
RORocío Olmedo-Requena
Rocío Olmedo-Requena
Lydia Maria Martin MartinLydia Maria Martin Martin
Lydia Maria Martin Martin
JJJose J. Jimenez-Moleon
Jose J. Jimenez-Moleon
The aims of this study were to study the mobility recovery in hip fracture patients and determine the influence of cognitive impairment on mobility within the first 3 months after surgery. This prospective cohort study was carried out in an acute public hospital in southern Spain and included 275 patients, 65 years or older, with a hip fracture. Mobility and Cognitive status were measured by Tinetti Performance-Oriented Mobility Assessment and Pfeiffers’ Scale (Short Portable Mental State Questionnaire), respectively. Multiple linear regression was used to examine the influence of cognitive impairment on mobility. The median Performance-Oriented Mobility Assessment score changed from 4 (3–4) points at discharge to 17 (7–22) at 3 months. All degrees of cognitive impairment were negatively associated with gait and balance at 1 and 3 months after surgery (P < 0.01). Age, weight bearing, length of hospital stay, and postsurgical complications were also identified as independent predictors of mobility outcome at 3 months. Cognitive impairment is a negative prognostic factor for the recovery of mobility in elderly patients with a hip fracture. New treatment strategies are needed for hip fracture patients with cognitive impairment.

MLMacarena Lozano
Macarena Lozano
RORocío Olmedo-Requena
Rocío Olmedo-Requena
MVMaría-Victoria Vega-Galindo
María-Victoria Vega-Galindo
Fernando Vázquez-AlonsoFernando Vázquez-Alonso
Fernando Vázquez-Alonso
AJAntonio Jimenez Jiménez-Pacheco
Antonio Jimenez Jiménez-Pacheco
JJJose J. Jimenez-Moleon
Jose J. Jimenez-Moleon
To analyze the association between prostate cancer (PCa) risk and night shift work, chronotype, and sleep duration in the context of a population-based case-control study of incident prostate cancer in Spain, a total of 465 PCa cases and 410 controls were analyzed. Selection criteria were: (i) age 40–80 years, and (ii) residence in the coverage area of the reference hospitals for ≥6 months before recruitment. Exposure variables were: (i) night shift work (permanent or rotating); (ii) chronotype: morning, neither, or evening (Munich ChronoType Questionnaire) and (iii) sleep duration according to the recommendations of the American National Sleep Foundation. PCa aggressiveness was determined according to the International Society of Urology Pathology classification. Adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) were estimated using logistic regression models. Night shift work was associated with PCa, aOR = 1.47 (95% CI 1.02–2.11), especially for rotating night shifts, aOR = 1.73 (95% CI 1.09–2.75). The magnitude of the association between ever night work and PCa was higher in evening subjects with aOR = 3.14 (95% CI 0.91–10.76) than in morning chronotypes with an aOR = 1.25 (95% CI 0.78–2.00). Working night shifts, especially rotating night shifts, could increase PCa risk. This risk may be higher in people with an evening chronotype.